Jamie Bacher Email & Phone Number

United States

Developing advanced enzymatic DNA synthesis. Get your long DNA fast - really fast. Great for HDR and nucleic acid therapeutics.

Berkeley, California, Us

QB3 and Bakar Labs, the incubator that we operate in partnership with UC Berkeley, both serve entrepreneurs translating new technology to solve the most important problems facing society. Through this program, we offer training for entrepreneurs, and hope to generate high-quality tenant companies for our incubator.

Consultant for industrial biotechnology / synthetic biology / ag biotechnology investors, startup companies and partners; ad hoc / informal advising to startups. Corporate and fundraising strategy; Technology strategy and IP; Program management; Outsourced technology development.• Critical Technology Evaluation and Advising: Assessing the impact, feasibility and technoeconomics of technology innovations within industrial biotechnology, agricultural biotechnology, synthetic biology, molecular biology, microbiology, and biochemistry.• Technology Strategy Development: Evaluating and crafting technology strategies that span from discovery through product development, fermentation, downstream processing, and ultimately to achieving commercial readiness.• Startup Advising and Assessment: Fundraising, shaping corporate structures, devising strategic plans, building effective teams, and enabling organizational growth.• IP Strategy: Navigating intellectual property landscapes, identifying both opportunities and threats within the biotech sector.

South San Francisco, California, Us

Boost Biomes develops desperately needed novel crop biological products, to help farmers transition from chemical products for their crops. Boost developed the first technology platform to identify the interactions between microbes, and deployed it to develop crop protection and crop nutrition products.* Communicate the need and vision* Bring together the resources and people to execute on the vision - raised ~$20M venture funding (series A during 2020 covid); in-licensed key platform IP from LBNL; multiple products developed through to EPA regulatory evaluation* Identify, create and capture opportunities - secured out-licensing and joint development agreements, worth ~$M, with global-scale, industry-leading organizations (DuPont/IFF, Yara, CGIAR)Boost participated in leading accelerator programs - some general (YC), some specific (Illumina, Thrive).

Synthetic biology startup dedicated to developing PKS and prenylating enzymes to generate high-value products in microbial fermentation. Secured funding (Breakout Labs, among others), IP (platform technology from Salk Institute) and partners.

Paris La Défense Cedex, Fr

Total New Energies executes a partnering strategy to participate in the biofuels sector; I was the liaison based at Amyris, the partner company.Co-led the ~$82M program of ~100 researchers at Amyris; managed project planning, resource tracking, identifying and filling technical gaps, and communication. Responsibilities and exposure spanned discovery research through development and manufacturing to downstream processing.

San Diego, Ca, Us

Leading VC-funded start-up company generating green algae for biofuel production.Championed and initiated research in ecology and evolution. Led teams to develop technical infrastructure that enabled company strain development programs and was critical for a $25M external partnership. My team generated the first modified algal strains in the company to be transferred to our outdoor pond facility for large-scale growth.

**Company acquired by Sapphire Energy**Startup biotechnology company focused on therapeutic protein production, using a green algae platform.Led strain improvement team to contribute to company achievement of a funding milestone with VCs valued at $1M financing to Rincon

La Jolla, California, Us

I studied the evolution of the genetic code in Paul Schimmel’s lab, which is recognized globally for contributions to studies of aminoacyl-tRNA synthetase evolution, biochemistry and disease involvement.I used bacterial genetics and directed evolution as well as initiated external collaborations, and developed Acinetobacter baylyi as an experimental genetic system.

Sunnyvale, California, Us

Company focus was on DNA shuffling to improve protein therapeutics.Reported to Chief Scientific Officer (and company co-Founder).Part of a team that developed a new platform of small, target-specific binding proteins. Contributed to this molecular screening program that was later spun-out.

Ph.D., Molecular Biology

Education record

B.Sc., Biology